Delivery Order SPE2DB24D2101-SPE2DB25FKGBA

Award Date 1/3/25
Potential Completion Date 1/27/25
Potential Value $4.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $13,618.40 Firm Fixed Price delivery order contract is for the supply of VEKLURY 100 MG vials, a critical pharmaceutical product. This award is a part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999, to provide a comprehensive range of medical commodities in...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,817.84 for the provision of VEKLURY 100 MG VIALS, a critical pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award is for the pharmaceutical product VEKLURY 100 MG VIALS, awarded to Amerisourcebergen Drug Corp's Corporate Office Division. The $6,809.20 firm fixed-price delivery order was placed by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). This contract does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense...
This federal contract award, valued at $8,171.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is for the delivery of VEKLURY 100 MG VIALS, a pharmaceutical product, with a completion date of June 24, 2024. This is a firm fixed-price delivery order contract. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has a significant Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $27,236.80, is for the supply of VEKLURY 100 mg vials, a critical pharmaceutical product. This order is placed under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,962.20 fixed-price delivery order contract is for the procurement of 100 mg vials of Veklury, a medication used to treat COVID-19. The contract has an ultimate completion date of January 30, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award is for the delivery of Veklury 100 mg vials to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 24, 2023, with a ceiling value of $2,041.02. The contract is a firm-fixed-price delivery order with a completion date of November 15, 2023. The award is not designated as a set-aside contract....
This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) is a delivery order (SPE2DB22D2211|SPE2DB25FRHYA) for the supply of VEKLURY 100 MG VIALS, valued at $2,042.76. The contract has a firm-fixed price and is set to be completed by November 20, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM.gov) since 2002. The contract is awarded by the Defense Logistics Agency (DLA), a...
This federal contract award is for the delivery of VEKLURY 100 MG VIALS to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract, valued at $3,404.60, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a completion date of March 15, 2024. Amerisourcebergen Drug Corp holds an...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The order is for the supply of VEKLURY 100 MG Vials, a pharmaceutical product, with a firm fixed price of $3,404.60 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which falls under a larger indefinite...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB25FKGBA
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,754.64 firm fixed-price delivery order contract is for the supply of VEKLURY 100 MG VIALS, a critical pharmaceutical product.

The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a comprehensive vehicle for providing a range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses a broad spectrum of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award does not have a set-aside designation, indicating open competition. As a prime contractor, Amerisourcebergen plays a vital role in supplying essential medical products to federal government agencies, particularly the military and veterans' healthcare systems, through its extensive distribution capabilities and supply chain.

Generated 4/4/25, 9:43 AM